Status:
COMPLETED
Autologous Tansfusion REquirements in Bone MArrow Harvest: The ATREMA Study
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Bone Marrow Donors
Eligibility:
All Genders
Brief Summary
Despite perioperative autologous donation (PAD) is widely used in healthy bone marrow (BM) donors to restrain the hemoglobin decrease after BM harvest, this practice is not supported by strong clinica...
Eligibility Criteria
Inclusion
- Familial donors qualified to donate BM hematopoietic stem cells and accepting to participate to this study
Exclusion
- Any planned deviation connected with abnormalities in the health status and/or laboratory tests of the donor, even though it does not prevent him from donation.
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2022
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT04355130
Start Date
March 20 2020
End Date
December 20 2022
Last Update
February 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, RM, Italy, 00168